Abstract:OBJECTIVE:To investigate clinical outcomes of ultrasound-guided percutaneous radiofrequency ablation (USG-RFA) in patients with renal clear cell carcinoma.METHODS:Medical records of 34 patients who underwent USG-RFA of renal clear cell carcinoma at the Department of Urology of the Affiliated Drum Tower Hospital of Medical School of Nanjing University from May 2009 to January 2014 were retrospectively reviewed, including 28 male and 6 female patients aged between 25 and 85 years (mean age 60.7 years). Of the included cases, 16 had tumors located in the left kidney, 16 in the right, 1 in the solitary kidney, and 1 in the bilateral kidney. There were 35 tumors in this study totally. The maximum diameter of the tumors was 1.8 to 5.0 cm (mean (2.7 ± 0.3) cm), of which 32 cases of renal tumors were ≤ 4.0 cm and 3 cases of renal tumors were > 4.0 cm to 5.0 cm. Pathological diagnosis were acquired by ultrasound-guided percutaneous biopsy after USG-RFA. Contrast-enhanced ultrasound was used to evaluate tumor outcomes at the time of the surgery, and multi-slice spiral CT enhanced scan and contrast-enhanced ultrasound were used to identify residues and recurrences after treatment.RESULTS:Treatments for all the patients were finished with short postoperative hospital stay about 3-5 days. No complications related to USG-RFA were encountered in any of the cases, such as perirenal fluid collection, perirenal hematoma, and peripheral organ damage. All the cases were diagnosed as clear cell carcinoma according to pathological results. The mean follow-up period was 29 ± 6 (range 3-59) months. Of the 35 USG-RFA-treated subjects, 32 tumors ≤ 4 cm reached the standard of complete treatment after one tumor was found with residue after the first month follow-up, and two tumors were noted recurrence at the 4 and 10 months follow-up after USG-RFA. Nonetheless, no residue or recurrence occurred after secondary treatment for these 3 tumors where pathological diagnosis were acquired again. The other 3 cases with tumors > 4.0 cm to 5.0 cm underwent USG-RFA twice or three times before reaching the standard of complete treatment, of which two had twice and one tumor had three times treatments. There was no carcinoma residue or recurrence during follow-up period.CONCLUSIONS:Percutaneous ultrasound-guided radiofrequency ablation for small renal mass (SRM) has satisfied clinical outcomes, with the advantage of less injury, lower complication rates and shorter recovery time for small size of renal clear cell carcinoma. USG-RFA may become the preferred treatment alternative for SRM.

Evaluation on Efficacy of Radiofrequency Ablation for Renal Cell Carcinoma with Multi-Slice Helical CT

Surgical Resection Plus Radiofrequency Ablation for the Treatment of Multifocal Hepatocellular Carcinoma.

Assessment of Treatment Efficacy in Radiofrequency Ablation for Renal Tumors by Contrast-Enhanced Ultrasonography

Application of Contrast-Enhanced Ultrasonography During Radiofrequency Ablation for Renal Tumors

[Ultrasound-Guided Percutaneous Radiofrequency Ablation Treatment for Renal Clear Cell Carcinoma].

Transcatheter arterial chemoembolization combined with radiofrequency ablation in treatment of renal cell carcinoma

Radiofrequency ablation using real-time ultrasonography–computed tomography fusion imaging improves treatment outcomes for T1a renal cell carcinoma: Comparison with laparoscopic partial nephrectomy

Laparoscopic Cool-Tip Radiofrequency Ablation for Renal Cell Carcinoma

Radiofrequency Ablation Guided by Cone Beam Computed Tomography for Hepatocellular Carcinoma: a Comparative Study of Clinical Results with the Conventional Spiral Computed Tomography-Guided Procedure.

Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients

Evaluation of Short-Term Efficiency and Affecting Factors of Radiofrequency Ablation Guided by Sonography in Hepatic Malignant Tumors

Ultrasound-guided radiofrequency ablation for the treatment of hepatic metastases:analysis of 136 cases

The Value of Contrast-Enhanced Magnetic Resonance Imaging and Diffusion Weighted Imaging in Percutaneous Cryoablation for Renal Cell Carcinoma

Prognostic Factors for Long-Term Survival in Patients with Renal-Cell Carcinoma after Radiofrequency Ablation.

Radiofrequency Ablation for Renal Cell Carcinoma in Functional Solitary Kidney

The Value of Cone-Beam CT-guided Radiofrequency Ablation in the Treatment of Pulmonary Malignancies (≤3 Cm).

The Application of Ultrasound-Guided Technology in Percutaneous Radiofrequency Ablation of Renal Tumors

Application of contrast-enhanced ultrasound and enhanced CT in diagnosis of liver cancer and evaluation of radiofrequency ablation

The Efficacy of Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization for Primary Hepatocellular Carcinoma in a Cohort of 487 Patients

Primary Hepatocellular Carcimoma after Transcatheter Arterial Chemoembolization (TAC) with Radiofrequency Ablation (RFA): Spectrum of CT and MR Imaging Findings

CT Arterioportography and CT Arteriography in Evaluating Therapeutic Response of Hepatic Malignancies after Radiofrequency Ablation